Patents by Inventor Fabrizio Vianello

Fabrizio Vianello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20200155659
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity.
    Type: Application
    Filed: November 12, 2019
    Publication date: May 21, 2020
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • Antifugetactic agents for the treatment of cancers
    Patent number: 10406217
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: September 10, 2019
    Assignee: The General Hospital Corporation
    Inventors: Mark C. Poznansky, John T. Potts, Jr., Fabrizio Vianello, Natalia Papeta
  • MODIFIED T-CELLS HAVING ANTI-FUGETACTIC PROPERTIES AND USES THEREOF
    Publication number: 20180273897
    Abstract: This invention provides ex vivo methods for making modified immune cell, e.g., T cell, compositions having overall anti-fugetactic properties for the effective and efficient treatment of tumors or cancers in a patient, and compositions and use thereof.
    Type: Application
    Filed: September 16, 2016
    Publication date: September 27, 2018
    Inventors: Mark C. Poznansky, Fabrizio Vianello
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180193438
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 12, 2017
    Publication date: July 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180161411
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 13, 2017
    Publication date: June 14, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099035
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099036
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides antifugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099034
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, Fabrizio Vianello, Natalia Papeta
  • ANTI-FUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099037
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts Jr., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20170319676
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: July 24, 2017
    Publication date: November 9, 2017
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • Anti-fugetactic agents for the treatment of ovarian cancer
    Patent number: 9789171
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: October 17, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mark C. Poznansky, John T. Potts, Jr., Fabrizio Vianello, Natalia Papeta
  • MODIFIED NATURAL KILLER CELLS HAVING ANTI-FUGETACTIC PROPERTIES AND USES THEREOF
    Publication number: 20170100433
    Abstract: This invention provides ex vivo methods for making modified natural killer cell compositions having overall anti-fugetactic properties for the effective and efficient treatment of tumors or cancers in a patient, and compositions and use thereof.
    Type: Application
    Filed: September 16, 2016
    Publication date: April 13, 2017
    Applicant: THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITAL
    Inventors: Mark C. POZNANSKY, Fabrizio VIANELLO
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF LIVER CANCERS
    Publication number: 20160193312
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: July 7, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, JR., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF SKIN CANCERS
    Publication number: 20160193311
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: July 7, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, JR., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREAMENT OF PANCREAS CANCER
    Publication number: 20160184257
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: June 30, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, JR., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20160166538
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: June 16, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, JR., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF BRAIN CANCERS
    Publication number: 20160166537
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides antifugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: June 16, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, Jr., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20160128976
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: May 12, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: MARK C. POZNANSKY, JOHN T. POTTS, Jr., FABRIZIO VIANELLO, NATALIA PAPETA
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF LUNG CANCER
    Publication number: 20160128975
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 9, 2015
    Publication date: May 12, 2016
    Applicant: The General Hospital Corporation dba Massachusetts General Hospital
    Inventors: Mark C. POZNANSKY, John T. POTTS, JR., Fabrizio VIANELLO, Natalia PAPETA
  • Purposeful Movement Of Human Migratory Cells Away From An Agent Source
    Publication number: 20080300165
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: November 4, 2005
    Publication date: December 4, 2008
    Applicant: The General Hospital Corporation
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta